CTRI/2017/04/008299已完成3 期
A Multicentric, Double Blind, Randomized, Active Control, Parallel Group Comparative Study to Evaluate the Efficacy, Safety and Tolerability of Nepafenac Ophthalmic Suspension 0.3 % w/v Vs. Bromfenac Ophthalmic Solution 0.09% w/v in the treatment of Patients with Pain and Inflammation in the Eye associated with Cataract Surgery.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and Female patients of age 18 - 70 years (Both inclusive).
- •2.Planned cataract extraction by phacoemulsification with the implantation of a posterior chamber intraocular lens.
- •3.Voluntary willingness to give written informed consent prior to participation in trial.
排除标准
- •1.Use of topical ocular, inhaled or systemic nonsteroidal anti-inflammatory drugs within 7 days of surgery, with the exception of the allowed low dose of aspirin (up to 100 mg) prior to surgery and through study exit.
- •2.Use of any form of steroids -topical, inhaled or systemic steroids within 14 days prior to surgery or local or oral NSAIDs within 7 days of surgery.
- •3.History of chronic or recurrent inflammatory eye disease (eg, iritis, scleritis, uveitis, iridocyclitis, rubeosis iridis) in the operative eye.
- •4.Pregnant and lactating women.
- •5.Known or suspected allergy or hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), or to any component of the test article.
- •6.Subjects with bleeding tendency, dry eye, rheumatoid arthritis, ocular surface disease including epithelial problems.
- •7.Subject with any surgery which converted from phacoemulsification to extra capsular surgery.
- •8.Patients with history of ocular surgery, inflammatory eye disease, ocular infection, congenital ocular anomalies, ocular trauma or current signs and symptoms that were associated with these or other ocular conditions.
- •9.Lens pseudoexfoliation syndrome with glaucoma or zonular compromise or previous ocular trauma.
- •10.Patients were also excluded if their IOP could not be reliably measured or had planned multiple surgical procedures, lens pseudoexfoliation syndrome with glaucoma or zonular compromise in the operative eye, ocular or systemic inflammatory or diabetic disease, or previous ocular trauma to the operative eye.
- •11.Patient with Diabetic Retinopathy, Glaucoma and any other Neurological condition.
- •12.Any other condition(s) that may affect the procedure of the study.
研究者
相似试验
已完成
3 期
Clinical Study to Compare the Efficacy and Safety of Vardenafil Tablet as compared with Sildenafil Tablet in Treatment of Erectile DysfunctioCTRI/2017/03/008014Ajanta Pharma Ltd219
已完成
3 期
A Clinical study to evaluate Efficacy, Safety and Tolerability of 2% Rebamipide ophthalmic suspension Vs 0.1 % Sodium Hyaluronate Ophthalmic solution for treatment of patients with Dry EyeCTRI/2015/05/005783Ajanta Pharma Ltd200
已完成
3 期
Fixed dose combination of Azilsartan medoxomil and Chlorthalidone for tratment of hypertensioCTRI/2017/12/010961SYNOKEM Pharmaceuticals Limited306
招募中
3 期
A multiple centre Phase III study of Azelnidipine in Newly Diagnosed Patients with Mild to Moderate Hypertension.CTRI/2015/08/006136Precise Chemipharma Pvt Ltd600
已完成
3 期
Effects of Levomilnacipran ER capsule for treatment of patients with major depressive disorder comparing to Venlafaxine hydrochloride XR capsuleCTRI/2017/10/010060MSN Laboratories Private Limited240